Fusion gene information | Fusion gene name: GABRA5-SCN9A |
Fusion gene ID: hg2558tg6335 | | Hgene | Tgene | Gene symbol | GABRA5 | SCN9A | Gene ID | 2558 | 6335 | Gene name | gamma-aminobutyric acid type A receptor subunit alpha5 | sodium voltage-gated channel alpha subunit 9 |
Synonyms | EIEE79 | ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP |
Cytomap | ('GABRA5')('SCN9A') 15q12 | 2q24.3 |
Type of gene | protein-coding | protein-coding |
Description | gamma-aminobutyric acid receptor subunit alpha-5GABA(A) receptor subunit alpha-5gamma-aminobutyric acid (GABA) A receptor, alpha 5gamma-aminobutyric acid type A receptor alpha5 subunit | sodium channel protein type 9 subunit alphahNE-Naneuroendocrine sodium channelperipheral sodium channel 1sodium channel protein type IX subunit alphasodium channel, voltage-gated, type IX, alpha polypeptidesodium channel, voltage-gated, type IX, alp |
Modification date | 20200313 | 20200313 |
UniProtAcc | P31644 | . |
Ensembl transtripts involved in fusion gene | ENST00000335625, ENST00000355395, ENST00000400081, ENST00000557449,
| |
Fusion gene scores | * DoF score | 2 X 3 X 2=12 | 5 X 4 X 4=80 |
# samples | 2 | 5 |
** MAII score | log2(2/12*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 |
Context | PubMed: GABRA5 [Title/Abstract] AND SCN9A [Title/Abstract] AND fusion [Title/Abstract] |
Most frequent breakpoint | GABRA5(27143092)-SCN9A(167221967), # samples:1
|
Anticipated loss of major functional domain due to fusion event. | |
Hgene | Tgene |
GABRA5
P31644 | . |
FUNCTION: Ligand-gated chloride channel subunit which is a component of the heteropentameric receptor for GABA, the major inhibitory neurotransmitter in the brain (PubMed:29961870, PubMed:31056671). May be involved in GABA-A receptor assembly, and GABA-A receptor immobilization and accumulation by gephyrin at the synapse (PubMed:31056671). {ECO:0000269|PubMed:29961870, ECO:0000269|PubMed:31056671}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | GABRA5 | C0005586 | Bipolar Disorder | 5 | PSYGENET |
Hgene | GABRA5 | C0001973 | Alcoholic Intoxication, Chronic | 1 | PSYGENET |
Hgene | GABRA5 | C0004352 | Autistic Disorder | 1 | CTD_human |
Hgene | GABRA5 | C0022333 | Jacksonian Seizure | 1 | CTD_human |
Hgene | GABRA5 | C0025261 | Memory Disorders | 1 | CTD_human |
Hgene | GABRA5 | C0036341 | Schizophrenia | 1 | PSYGENET |
Hgene | GABRA5 | C0036572 | Seizures | 1 | CTD_human |
Hgene | GABRA5 | C0149958 | Complex partial seizures | 1 | CTD_human |
Hgene | GABRA5 | C0150080 | Social Communication Disorder | 1 | CTD_human |
Hgene | GABRA5 | C0233794 | Memory impairment | 1 | CTD_human |
Hgene | GABRA5 | C0234533 | Generalized seizures | 1 | CTD_human |
Hgene | GABRA5 | C0234535 | Clonic Seizures | 1 | CTD_human |
Hgene | GABRA5 | C0270824 | Visual seizure | 1 | CTD_human |
Hgene | GABRA5 | C0270844 | Tonic Seizures | 1 | CTD_human |
Hgene | GABRA5 | C0270846 | Epileptic drop attack | 1 | CTD_human |
Hgene | GABRA5 | C0422850 | Seizures, Somatosensory | 1 | CTD_human |
Hgene | GABRA5 | C0422852 | Seizures, Auditory | 1 | CTD_human |
Hgene | GABRA5 | C0422853 | Olfactory seizure | 1 | CTD_human |
Hgene | GABRA5 | C0422854 | Gustatory seizure | 1 | CTD_human |
Hgene | GABRA5 | C0422855 | Vertiginous seizure | 1 | CTD_human |
Hgene | GABRA5 | C0424605 | Developmental delay (disorder) | 1 | GENOMICS_ENGLAND |
Hgene | GABRA5 | C0494475 | Tonic - clonic seizures | 1 | CTD_human |
Hgene | GABRA5 | C0525045 | Mood Disorders | 1 | PSYGENET |
Hgene | GABRA5 | C0557874 | Global developmental delay | 1 | GENOMICS_ENGLAND |
Hgene | GABRA5 | C0751056 | Non-epileptic convulsion | 1 | CTD_human |
Hgene | GABRA5 | C0751110 | Single Seizure | 1 | CTD_human |
Hgene | GABRA5 | C0751123 | Atonic Absence Seizures | 1 | CTD_human |
Hgene | GABRA5 | C0751292 | Age-Related Memory Disorders | 1 | CTD_human |
Hgene | GABRA5 | C0751293 | Memory Disorder, Semantic | 1 | CTD_human |
Hgene | GABRA5 | C0751294 | Memory Disorder, Spatial | 1 | CTD_human |
Hgene | GABRA5 | C0751295 | Memory Loss | 1 | CTD_human |
Hgene | GABRA5 | C0751494 | Convulsive Seizures | 1 | CTD_human |
Hgene | GABRA5 | C0751495 | Seizures, Focal | 1 | CTD_human |
Hgene | GABRA5 | C0751496 | Seizures, Sensory | 1 | CTD_human |
Hgene | GABRA5 | C1510586 | Autism Spectrum Disorders | 1 | CTD_human |
Hgene | GABRA5 | C3495874 | Nonepileptic Seizures | 1 | CTD_human |
Hgene | GABRA5 | C3711376 | Isodicentric Chromosome 15 Syndrome | 1 | CTD_human |
Hgene | GABRA5 | C4048158 | Convulsions | 1 | CTD_human |
Hgene | GABRA5 | C4316903 | Absence Seizures | 1 | CTD_human |
Hgene | GABRA5 | C4317109 | Epileptic Seizures | 1 | CTD_human |
Hgene | GABRA5 | C4317123 | Myoclonic Seizures | 1 | CTD_human |
Hgene | GABRA5 | C4505436 | Generalized Absence Seizures | 1 | CTD_human |
Tgene | | C0014805 | Primary Erythermalgia | 15 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | | C0014544 | Epilepsy | 6 | CLINGEN |
Tgene | | C1833661 | PAROXYSMAL EXTREME PAIN DISORDER | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | | C0751122 | Infantile Severe Myoclonic Epilepsy | 4 | CTD_human;ORPHANET |
Tgene | | C1855739 | Indifference to Pain, Congenital, Autosomal Recessive | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | | C0014804 | Erythromelalgia | 3 | CTD_human |
Tgene | | C2751778 | Generalized Epilepsy With Febrile Seizures Plus, 7 | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | | C0002768 | Congenital Pain Insensitivity | 2 | GENOMICS_ENGLAND;ORPHANET |
Tgene | | C0019372 | Herpesviridae Infections | 1 | CTD_human |
Tgene | | C0020072 | Hereditary Sensory Autonomic Neuropathy, Type 2 | 1 | ORPHANET |
Tgene | | C0020075 | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1 | ORPHANET |
Tgene | | C0027796 | Neuralgia | 1 | CTD_human |
Tgene | | C0032768 | Postherpetic neuralgia | 1 | CTD_human |
Tgene | | C0033774 | Pruritus | 1 | CTD_human |
Tgene | | C0037140 | B Virus Infection | 1 | CTD_human |
Tgene | | C0038870 | Neuralgia, Supraorbital | 1 | CTD_human |
Tgene | | C0042656 | Neuralgia, Vidian | 1 | CTD_human |
Tgene | | C0150055 | Chronic pain | 1 | CTD_human |
Tgene | | C0234247 | Neuralgia, Atypical | 1 | CTD_human |
Tgene | | C0234249 | Neuralgia, Stump | 1 | CTD_human |
Tgene | | C0270914 | Hereditary Motor and Sensory-Neuropathy Type II | 1 | ORPHANET |
Tgene | | C0423711 | Neuralgia, Perineal | 1 | CTD_human |
Tgene | | C0423712 | Neuralgia, Iliohypogastric Nerve | 1 | CTD_human |
Tgene | | C0432262 | Dysosteosclerosis | 1 | GENOMICS_ENGLAND |
Tgene | | C0598589 | Inherited neuropathies | 1 | GENOMICS_ENGLAND |
Tgene | | C0699739 | Sensory Neuropathy, Hereditary | 1 | GENOMICS_ENGLAND |
Tgene | | C0751371 | Neuralgia, Ilioinguinal | 1 | CTD_human |
Tgene | | C0751372 | Nerve Pain | 1 | CTD_human |
Tgene | | C0751373 | Paroxysmal Nerve Pain | 1 | CTD_human |
Tgene | | C3178789 | Widespread Chronic Pain | 1 | CTD_human |
Tgene | | C4551549 | Early Infantile Epileptic Encephalopathy 6 | 1 | GENOMICS_ENGLAND |